Editor’s note: Find the current COVID-19 news and assistance in Medscape’s Coronavirus Resource Center.
About 15 million dosages of the Johnson & Johnson COVID-19 vaccine were destroyed after workers at a factory mixed up ingredients, The New York Times reported.
.
The Baltimore, MD, strategy is operated by a business called Emergent BioSolutions, the Times said. The business deals with both Johnson & Johnson and AstraZeneca.
The error has stopped deliveries of the vaccine up until the FDA examines, the paper said. The mishap, nevertheless, does not impact dosages of the J&J one-shot vaccine already delivered and being used.
The issue is that 10s of countless doses were expected to come from the Baltimore plant.
The Associated Press reported that Emergent has had various problems with the FDA, with the agency mentioning the business for badly trained employees, broken vials and mold.
The records cover examinations at Emergent centers, including Bayview, because 2017.
On The Other Hand, in a statement, Johnson & Johnson said its own quality control procedure identified the problem in one batch of components.
The company said it prepares to still seek emergency situation use authorization for a various Emergent facility and will offer more specialists on site at Emergent.
The Times reports that President Joe Biden’s team still believes the administration can fulfill its dedication to have enough vaccine doses to inoculate every grownup by the end of May.
Johnson & Johnson said it still prepares to provide an extra 24 million doses through April.
Sources:
The New York City Times: “ Johnson & Johnson Covid-19 vaccine dosages are delayed by a U.S. factory mix-up.”
Johnson & Johnson: “Johnson & Johnson Statement on U.S. COVID-19 Vaccine Production.”
The Associated Press: “Johnson & Johnson COVID-19 vaccine batch stops working quality check.”
No comments:
Post a Comment